Back to Evidence
Paper-scoped peptide mentionSequence reported

PCR12mod6

PMC12444544::PEP000002

Source publication

Rational Design of PCR12mod6, a Cathelicidin-HR-Derived Peptide with Enhanced Dual-Action Antimicrobial and Antioxidant Activity

ACS Omega · 2025

Sequence status
reported
Standardization
Sequence ready
Source location
unknown
Activity records
25

Sequence evidence

Reported molecular identity

PCRKIFCRWKKR

PCRKIFCRWKKR

Resolved peptide links

Experimental observations

Records linked to this mention

ImmunomodulatoryAnti-inflammatoryPositive observation
Record detail

Figure 7A: PCR12mod6 reduced NO production to 69.11% of control at 250 μg/mL in LPS-stimulated RAW 264.7 cells.

Measure
percent_inhibition
Value
69.11% of control
Target
RAW 264.7
Assay
Not reported by source
Source publication
ImmunomodulatoryAnti-inflammatoryPositive observation
Record detail

Figure 7A: PCR12mod6 reduced NO production to 41.66% of control at 500 μg/mL in LPS-stimulated RAW 264.7 cells.

Measure
percent_inhibition
Value
41.66% of control
Target
RAW 264.7
Assay
Not reported by source
Source publication

Local peptide labels such as P1, PEP1, or peptide 1 are grouped only within this paper and are not assumed to represent the same molecule across publications.